PTC Therapeutics Inc (PTCT)

51.67 +0.72  +1.41% NASDAQ Jun 3, 12:58 Delayed 2m USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
08/06/2020 16:30 EDT Misc PTC Therapeutics Inc Second Quarter Earnings Conference Call in 2020
08/06/2020 Earnings PTC Therapeutics Inc Second Quarter Earnings in 2020 Release
06/10/2020 09:00 EDT Misc PTC Therapeutics Inc Annual General Meeting for 2019
04/30/2020 16:30 EDT Misc PTC Therapeutics Inc First Quarter Earnings Conference Call for 2020
04/30/2020 Earnings PTC Therapeutics Inc First Quarter Earnings Result for 2020
03/02/2020 16:30 EST Misc PTC Therapeutics Inc Fourth Quarter Earnings Conference Call for 2019
03/02/2020 Earnings PTC Therapeutics Inc Fourth Quarter Earnings in 2019 Release
03/02/2020 Misc PTC Therapeutics Inc Annual Report for 2019
10/29/2019 16:30 EDT Misc PTC Therapeutics Inc Third Quarter Earnings Conference Call for 2019
10/29/2019 Earnings PTC Therapeutics Inc Third Quarter Earnings in 2019 Release
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: https://www.ptcbio.com
  • Investor Relations URL: http://ir.ptcbio.com/
  • HQ State/Province: New Jersey
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Growth
  • Next Earnings Release: Aug. 06, 2020
  • Last Earnings Release: Apr. 30, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: PTC Therapeutics Inc is a global biopharmaceutical company focused on the discovery, development, and commercialization of orally administered, small-molecule therapeutics. Its target area is RNA biology post-transcriptional control processes of the events occurring in a cell when a RNA messenger is copied from DNA during the transcription process. The discovered products address multiple therapeutic areas, including rare disorders, such as nonsense mutations in Duchenne muscular dystrophy and oncology.

Top Fund Holders

Symbol Name Weighting
MFMS MFAM Small-Cap Growth ETF 3.72%
GNOM Global X Genomics & Biotechnology ETF 3.55%
FRBRX Franklin Biotechnology Discovery R6 3.25%
SBIO ALPS Medical Breakthroughs ETF 2.82%
PBE Invesco Dynamic Biotech & Genome ETF 2.23%
BBP Virtus LifeSci Biotech Products ETF 2.22%
FSSRX Franklin Small Cap Growth R 1.61%
FPHAX Fidelity® Select Pharmaceuticals Port 1.43%
FBIOX Fidelity® Select Biotechnology 1.28%
NSNRX Neuberger Berman Small Cap Growth R3 1.27%
GSCZX GuideStone Funds Small Cap Equity Inv 0.60%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.